Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Equtiy Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at March 31, 2023:

 

    Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     54,294 *     39,359 **     14,935  

 

* Increased by 8,691 on January 1, 2023, representing 4% of the total number of shares of common stock outstanding on December 31, 2022.
** Includes both restricted stock grants and option grants
Schedule of Recognized Stock Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

    Three Months Ended March 31,  
    2023     2022  
Research and Development   $ 553     $ 550  
General and Administrative     719       710  
Total   $ 1,272     $ 1,260  
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the three months ended March 31, 2023:

 

    Stock Options  
Outstanding at December 31, 2022     34,739  
Granted     20  
Exercised     -  
Forfeited     (81 )
Expired     -  
Outstanding at March 31, 2023     34,678